CONDITIONS

Orthopedic Applications

Orthopedic applications: 

Indication:

Shoulder 

Elbow 

  • Rotator Cuff Tendonitis, Tendonopathy or partial tear
  • Supraspinatus Tendonitis
  • Acromo-clavicular joint pain or arthritis
  • Bicipital tendonitis

 

  • Lateral Epicondylitis (Tennis Elbow)
  • Medial Epicondylitis (Golfer’s Elbow)
  • Ulnar Collateral ligament Sprain or tear

 

Wrist 

Hip & Pelvic 

  • De quervain’s tenosynovitis
  • Chronic Thumb Pain

 

  • Trochanteric Bursitis
  • Hamstring Strain
  • SI Joint Pain

 

Knee 

Leg & Foot 

  • Patellar Tendonitis /Tendinosis
  • Quadriceps muscle injuries
  • Ligament strains or tears
  • Arthritis of the knee joint
  • Lliotibial band syndrome
  • Achillies Tendonitis
  • Plantar faciitis
  • Peroneal Tendonitis

 

 

Cardiovascular Applications

Cardiovascular Applications: Coming Soon!

LCBSC’s:

The isolation of CD34+ cells from human umbilical cord blood (CB) is an important step in hematopoietic stem and progenitor cell (HSPC) research. Great care must be taken to isolate CD34+ cells with high purities and yields as the frequency of CD34+ cells in CB is low (typically 0.1 - 1% of nucleated cells), sample volumes are small, and cell quality and viability can be variable between different CB samples.

CD34+ selected cells are a highly purified population of progenitor cells and allow for greater cell expansion and differentiation down multiple pathways. CD34+ and CD133+ progenitors can differentiate into a number of precursors and differentiated cell types. Hypothesis is that CBSC’s contains cytokines, growth factors and markers to support angiogenesis and improve cardiac muscle.

Hematopoietic progenitors express high levels of the cell surface glycoprotein CD34. As these cells mature and differentiate, the levels of CD34 decrease. CD34+ cells are capable of initiating long-term hematopoiesis both in vitro and in vivo and are therefore utilized in the therapeutic re-constitution of cord blood.

 

Oncology Applications

"Suppression of cancer cell proliferation by selective Single Domain Antibody"